These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 18642350)

  • 1. Dopamine D1 receptor ligands: where are we now and where are we going.
    Zhang J; Xiong B; Zhen X; Zhang A
    Med Res Rev; 2009 Mar; 29(2):272-94. PubMed ID: 18642350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational analysis of D1 dopamine receptor agonists: pharmacophore assessment and receptor mapping.
    Mottola DM; Laiter S; Watts VJ; Tropsha A; Wyrick SD; Nichols DE; Mailman RB
    J Med Chem; 1996 Jan; 39(1):285-96. PubMed ID: 8568818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 8,9-dihydroxy-1,2,3,11b-tetrahydrochromeno[4,3,2,-de]isoquinoline (dinoxyline), a high affinity and potent agonist at all dopamine receptor isoforms.
    Grubbs RA; Lewis MM; Owens-Vance C; Gay EA; Jassen AK; Mailman RB; Nichols DE
    Bioorg Med Chem; 2004 Mar; 12(6):1403-12. PubMed ID: 15018913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further definition of the D1 dopamine receptor pharmacophore: synthesis of trans-6,6a,7,8,9,13b-hexahydro-5H-benzo[d]naphth[2,1-b]azepines as rigid analogues of beta-phenyldopamine.
    Negash K; Nichols DE; Watts VJ; Mailman RB
    J Med Chem; 1997 Jul; 40(14):2140-7. PubMed ID: 9216832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dihydrexidine--the first full dopamine D1 receptor agonist.
    Salmi P; Isacson R; Kull B
    CNS Drug Rev; 2004; 10(3):230-42. PubMed ID: 15492773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists.
    Ryman-Rasmussen JP; Nichols DE; Mailman RB
    Mol Pharmacol; 2005 Oct; 68(4):1039-48. PubMed ID: 15985612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the full dopamine D1 receptor agonist dihydrexidine in Parkinson's disease.
    Blanchet PJ; Fang J; Gillespie M; Sabounjian L; Locke KW; Gammans R; Mouradian MM; Chase TN
    Clin Neuropharmacol; 1998; 21(6):339-43. PubMed ID: 9844789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative molecular field analysis-based prediction of drug affinities at recombinant D1A dopamine receptors.
    Brusniak MY; Pearlman RS; Neve KA; Wilcox RE
    J Med Chem; 1996 Feb; 39(4):850-9. PubMed ID: 8632409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analogues of doxanthrine reveal differences between the dopamine D1 receptor binding properties of chromanoisoquinolines and hexahydrobenzo[a]phenanthridines.
    Cueva JP; Chemel BR; Juncosa JI; Lill MA; Watts VJ; Nichols DE
    Eur J Med Chem; 2012 Feb; 48():97-107. PubMed ID: 22204903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. trans-2,3-dihydroxy-6a,7,8,12b-tetrahydro-6H-chromeno[3,4-c]isoquinoline: synthesis, resolution, and preliminary pharmacological characterization of a new dopamine D1 receptor full agonist.
    Cueva JP; Giorgioni G; Grubbs RA; Chemel BR; Watts VJ; Nichols DE
    J Med Chem; 2006 Nov; 49(23):6848-57. PubMed ID: 17154515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and pharmacological evaluation of substituted naphth[1,2,3-de]isoquinolines (dinapsoline analogues) as D1 and D2 dopamine receptor ligands.
    Qandil AM; Lewis MM; Jassen A; Leonard SK; Mailman RB; Nichols DE
    Bioorg Med Chem; 2003 Apr; 11(7):1451-64. PubMed ID: 12628671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of D₁ receptor-agonist interactions and D₁/D₂ agonist selectivity using a combination of pharmacophore and receptor homology modeling.
    Malo M; Brive L; Luthman K; Svensson P
    ChemMedChem; 2012 Mar; 7(3):483-94, 338. PubMed ID: 22315216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective pharmacophore models of dopamine D(1) and D(2) full agonists based on extended pharmacophore features.
    Malo M; Brive L; Luthman K; Svensson P
    ChemMedChem; 2010 Feb; 5(2):232-46. PubMed ID: 20077461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the extracellular amino terminus and first membrane-spanning helix of dopamine D1 and D5 receptors in shaping ligand selectivity and efficacy.
    D'Aoust JP; Tiberi M
    Cell Signal; 2010 Jan; 22(1):106-16. PubMed ID: 19786093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the enantiomers of (+/-)-doxanthrine, a high efficacy full dopamine D(1) receptor agonist, and a reversal of enantioselectivity at D(1) versus alpha(2C) adrenergic receptors.
    Przybyla JA; Cueva JP; Chemel BR; Hsu KJ; Riese DJ; McCorvy JD; Chester JA; Nichols DE; Watts VJ
    Eur Neuropsychopharmacol; 2009 Feb; 19(2):138-46. PubMed ID: 19028082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent progress in development of dopamine receptor subtype-selective agents: potential therapeutics for neurological and psychiatric disorders.
    Zhang A; Neumeyer JL; Baldessarini RJ
    Chem Rev; 2007 Jan; 107(1):274-302. PubMed ID: 17212477
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of cis- and trans-9- and 11-hydroxy-5,6,6a,7,8,12b-hexahydrobenzo[a]phenanthridines as structurally rigid, selective D1 dopamine receptor ligands.
    Brewster WK; Nichols DE; Watts VJ; Riggs RM; Mottola D; Mailman RB
    J Med Chem; 1995 Jan; 38(2):318-27. PubMed ID: 7830274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The structural evolution of dopamine D3 receptor ligands: structure-activity relationships and selected neuropharmacological aspects.
    Boeckler F; Gmeiner P
    Pharmacol Ther; 2006 Oct; 112(1):281-333. PubMed ID: 16905195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The roles of dopamine and serotonin, and of their receptors, in regulating sleep and waking.
    Monti JM; Jantos H
    Prog Brain Res; 2008; 172():625-46. PubMed ID: 18772053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of the effects of dopamine D(1) agonists on eye blinking in rats.
    Desai RI; Neumeyer JL; Bergman J; Paronis CA
    Behav Pharmacol; 2007 Dec; 18(8):745-54. PubMed ID: 17989512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.